Seroquel 12-Week Data Is Longest In Class For Acute Bipolar Disorder Monotherapy
This article was originally published in The Pink Sheet Daily
Executive Summary
The efficacy of AstraZeneca’s quetiapine was established in two 12-week monotherapy trials, revised labeling states. Seroquel’s original bipolar indication was based upon three-week trial data.